View Clinical Trial (Medical Research Study)
AZD8683 Single Ascending Dose Study - NCT00979849-(Clinical Trial 331561)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Philadelphia |
|
State:
|
|
PA |
| Zip Code: |
|
|
| Conditions: |
|
Healthy Volunteers |
| Purpose: |
|
The aim of the study is to assess the safety, tolerability, pharmacokinetics and
pharmacodynamics of AZD8683 following single ascending dose administrations in healthy male
subjects.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Provision of signed, written and dated informed consent prior to any study specific
procedures
- Have a body mass index (BMI) between 19 and 30 kg/m2 and weigh at least 50 kg and no
more than 100 kg
- Be non-smoker or ex-smoker who has stopped smoking (or using other nicotine products)
for >6 months prior to study start
Exclusion Criteria:
- Any clinically significant disease or disorder
- Any clinically significant abnormalities at screening examinations
- Use any prescribed or non-prescribed medication |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 17, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|